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Transforming growth factor-b1 (TGF-b1) in¯uences the morphogenesis of many organs, regulating cell growth, differentia-
tion, gene expression, extracellular matrix deposition, and angiogenesis. In order to assess the effects of TGF-b1 on lung
development in vivo, transgenic mice were generated bearing a chimeric gene composed of human surfactant protein C
(SP-C) gene promoter and the porcine TGF-b1 cDNA mutated to ensure constitutive activation of the TGF-b1 peptide.
Because of the perinatal loss related to the SP-C±TGF-b1 transgene, embryos bearing the transgene were obtained on Days
16 and 18.5 of gestation. TGF-b1 was selectively expressed in respiratory epithelial cells of the transgenic embryos. Body
weight, length, and lung size were not altered in the transgenic embryos; however, lung morphogenesis of Day 18.5
transgenic mice was arrested in a late pseudoglandular stage of development, while that of their nontransgenic littermates
was typical of the saccular stage. Lungs of transgenic mice on Day 16 contained fewer acinar buds than those of non-
transgenic littermates. At both ages, epithelial cell differentiation, assessed by the expression of Clara cell secretory protein2
and pro-SP-C, was inhibited. While collagen III deposition was not affected by the transgene, collagen I expression was
persistent in terminal airways of fd 18.5 transgenic lungs. The distribution of a-smooth muscle actin was markedly altered,
being detected in the mesenchyme surrounding the distal leading edges of epithelial tubules in the SP-C±TGF-b1 transgenic
mice. Expression of TGF-b1 in the developing respiratory epithelium of transgenic mice arrested lung sacculation and
epithelial cell differentiation in vivo, supporting the role of TGF-b family members in lung morphogenesis and differentia-
tion. q 1996 Academic Press, Inc.
INTRODUCTION tion with the expression of Clara cell secretory protein
(CCSP) (Wert et al., 1993). Concomitantly surfactant pro-
Lung development in the mouse begins at 9.5 days post tein gene expression increases markedly in the distal airway
coitum (pc) with the outgrowth of paired lung buds from the epithelium in association with Type II cell differentiation
foregut endoderm that invades the mesenchyme. Epithelial and surfactant production (Wert et al., 1993). Autocrine and
tubes undergo a de®ned pattern of branching morphogenesis paracrine interactions between mesenchymal and epithelial
to form the conducting airways and terminal acinar buds cells, as well as cell±matrix interactions, have been impli-
during the pseudoglandular stage (9.5 to 16 days pc). Termi- cated in the regulation of branching morphogenesis, termi-
nal lung buds then dilate during the canalicular stage (16 nal airway remodeling, and differentiation of respiratory ep-
to 17 days pc) and further dilate to form sac-like structures ithelial cells (Minno and King, 1994; Guzowski et al., 1990;
during the saccular stage (17 days pc to birth), a process Roman et al., 1991).
accompanied by the thinning of mesenchyme and the inva- Transforming growth factor-b1 (TGF-b1), a member of a
gination of blood vessels. Epithelial cells in the conducting family of proteins in¯uencing growth, differentiation, and
airways differentiate during the canalicular stage in associa- morphogenesis (Rizzino, 1988; Pelton and Moses, 1990; Mo-
ses et al., 1990; Massague, 1990), has been implicated in the
regulation of fetal lung development. TGF-b1 is expressed1 To whom correspondence should be addressed.
during morphogenesis of the fetal lung (Heine et al., 1987;2 Abbreviations used: CCSP, Clara cell secretory protein; ECM,
Lehnert and Akhurst, 1988; Pelton et al., 1990; Schmid etextracellular matrix; EGF, epidermal growth factor; PCNA, prolif-
al., 1991). Colocalization of TGF-b1 protein with collagenerating cell nuclear antigen; SP-A, surfactant Protein-A; SP-C, sur-
I, collagen III, and ®bronectin in the developing lung sug-factant Protein-C; TGF-b1, transforming growth factor-b1; WAP,
whey±acidic protein. gests that it may in¯uence lung development by regulating
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The transverse sections through the thorax of the embryos werethe deposition of extracellular matrix (Heine et al., 1990).
loaded on silane-coated slides. The paraf®n sections were deparaf-TGF-b1 inhibited SP-A (Whitsett et al., 1987) and SP-C
®nized and the frozen sections were post®xed in 4% paraformalde-(Maniscalco et al., 1994) expression in embryonic fetal lung
hyde and then stained with hematoxylin and eosin.in vitro, inhibiting stimulatory effects of epidermal growth
factor (EGF) on surfactant protein (Whitsett et al., 1987) and
lipid synthesis (Torday and Kourembanas, 1990), supporting Morphometric Analysis
its potential inhibitory role in lung epithelial maturation.
Lungs from transgenic mice and their nontransgenic littermatesTGF-b1 reversibly blocked branching morphogenesis of fe-
at 16 days pc were studied using six serial transverse sections pertal lung explants in vitro (Serra et al., 1994), supporting the
mouse lung at 50-mm intervals. Lung sections (5 mm) were stainedconcept that TGF-b1 may in¯uence lung morphogenesis
with hematoxylin and eosin before the measurements. Morpho-
and epithelial cell differentiation. metric measurements were determined using Image-1/Metamorph
In the present study, transgenic mouse embryos were gen- Imaging System, Version 2 for Microsoft Windows (Universal Im-
erated in which TGF-b1 was expressed in distal respiratory aging Corp., 1994). Calibration for 81 images were made by acquir-
epithelial cells directed by the surfactant protein-C (SP-C) ing micrometer images at 81. These images were then used to
gene promoter. Expression of TGF-b1 blocked sacculation determine the number of pixels per micrometer. The left lung on
each section was assessed, with the total area being measured andof the distal respiratory tract, inhibited epithelial cell differ-
the total number of terminal acinar buds being counted. The termi-entiation, and caused abnormal distribution of collagen I
nal acinar buds contained in the left lung of each section wereand a-smooth muscle actin.
expressed as number of acinar buds/mm2. Means, standard devia-
tions, and standard errors were determined. The P values were
calculated by Fisher's test.
MATERIALS AND METHODS
In Situ HybridizationChimeric SP-C±pTGF-b1±t Intron-Poly A Gene
The SV40±t-intron-poly A DNA fragment (478 bp) was subclonedPorcine TGF-b1 cDNA, in which the Cys223 and Cys225 codons
into a pBluescript (SK/) transcription vector containing the T3 andhad been replaced with serine codons by site-directed mutagenesis
T7 promoters. The transcription vectors were used to generate(Brunner et al., 1989), was kindly provided by the laboratory of Dr.
sense and anti-sense riboprobes which were labeled with 35S-UTPMichael B. Sporn, National Institute of Health. This KpnI fragment
(speci®c activity: 1412 Ci/mmole, New England Nuclear Inc.). Plas-was placed 3* to the 3.7 SP-C fragment in the 3.7 SP-C±t intron-
mids were linearized and RNA synthesis was performed using ei-poly A in a PUC 18 plasmid (Whitsett et al., 1992).
ther the T3 or T7 polymerase and reagents contained in the Ribro-
probe Gemini Core System II transcription kit (Promega, Inc.). Pre-
treatment of tissues for in situ hybridization was performed asProduction of Transgenic Embryos
described previously (Wert et al., 1993). Hydrolyzed ribroprobe frag-
Plasmid containing the chimeric gene was propagated in Esche- ments of 0.2 kb (106 cpm/ml) were applied to 5-mm paraf®n sections
richia coli DH 5a using standard methodology. Expression cas- and 10-mm cryostat sections and hybridized at 427C for 13±16 hr.
settes were liberated by NotI and NdeI nuclease digestion and DNA Tissue sections were then washed in 50% formamide, 51 SSC (11
was fractionated by gel electrophoresis. DNA was extracted from SSC is 0.15 M NaCl, 0.15 M Na citrate, pH 7.0) and 20 mM DTT
agarose using the QIAEX extraction kit. Puri®ed DNA was dialyzed at 557C for 60 min, rinsed in 500 mM NaCl, 10 mM Tris±HCl (pH
extensively into 5 mM Tris±HCl, pH 7.4, 0.1 mM EDTA and then 7.5), 5 mM EDTA, and treated with 20 mg/ml RNase A for 30 min
microinjected into fertilized eggs of FVB/N mice. Embryos at 16 at 377C, followed by a series of washes at room temperature with
and 18.5 days of gestation were obtained from pregnant mothers. decreasing concentrations of 21 to 0.11 SSC and 1 mM DTT. Slides
Transgenic embryos were identi®ed by PCR reaction of tail DNA were autographed with Ilford K5 nuclear track emulsion for 3±7
using the following oligo primers: upper primer, 5*-CGAGCCAGA- days at 47C and developed with Kodak D19 developer. Selected
GGCGGACTACTAC-3*; lower primer, 5*-CCCCGGCGGCCA- examples of hybridization results were photographed with dark®eld
GAAT-3*. The primers span introns, and the DNA sequence of the illumination.
primers differ signi®cantly from corresponding sequence in mouse
TGF-b1 DNA (4/22 bp for the upper primer and 8/16 bp for the
lower primer). Therefore, the right size PCR product speci®cally Antibodies and Immunostaining
represents the ampli®cation of porcine TGF-b1 cDNA fragment.
Rabbit polyclonal anti-pro-TGF-b1 antibody (LC 1-30) was kindlyThe speci®city of PCR product was also con®rmed by restriction
provided by Dr. Kathleen Flanders (Laboratory of Chemopreven-digestion and Southern blot analysis.
tion, NCI, Bethesda, MD) and was used at a dilution of 1:10. Rabbit
anti-collagen I polyclonal antiserum was obtained from Chemicon
International, Inc. and was used at a dilution of 1:800. Af®nity-Tissue Preparation and Histopathology
puri®ed goat anti-collagen III antibody was obtained from Southern
Biotechnology Association, Inc. and was used at a dilution of 1:150.Mouse embryos were ®xed in neutral buffered 4% paraformalde-
hyde for 16 hr at 47C. Some embryos were dehydrated through a FITC-conjugated mouse monoclonal anti-a-smooth muscle actin
antibody was obtained from Sigma Chemical Co. and was usedgraded series of ethanol solutions and embedded in paraf®n; the
other embryos were cryoprotected by incubation in 30% neutral at a dilution of 1:50. Human polyclonal antibody against human
proliferating cell nuclear antigen (PCNA) was obtained from Immu-buffered sucrose followed by freezing in M1 embedding medium.
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serine codons by site-directed mutagenesis to ensure the
constitutive activation of TGF-b1 (Brunner et al., 1989).
Because of perinatal loss related to the SP-C±TGF-b1
transgene in preliminary experiments, transgenic mice were
sacri®ced prior to birth. After microinjection of transgene
into fertilized eggs of FVB/N mice, 74 embryos at 18.5 days
of gestation were collected from 12 pregnant mothers, and
13 embryos at 16 days of gestation were obtained from 4
pregnant mothers. Eleven Day-18.5 and four Day-16 em-
bryos carried the transgene as identi®ed by PCR (data not
shown).
FIG. 1. Construction of the 3.7 human SP-C-porcine TGF-b1-t
intron-poly A chimeric gene. A 5.7-kbp Nde1-Not1 DNA fragment Expression of the SP-C±TGF-b1 Transgenewas used for microinjection. A 1.3-kbp modi®ed porcine TGF-b1
cDNA was inserted into the Kpn1 site in the polylinker region The intrinsic polyadenylation signal of porcine TGF-b1
between SP-C 3.7 and SV40 t intron-poly A fragments. The TGF- cDNA, ATTAAA, deviates from the canonical signal, AAT-
b1 translational start and stop codons and polyadenylation signal AAA, and therefore allows the transcript to read through
are indicated. A 1-kbp size bar is provided. Arrows (a) indicate the this polyadenylation signal into the downstream SV40±t
sites of primers used for PCR genotyping. Bar (b) represents a 0.47-
intron-polyA sequence (Jhappan et al., 1993). More than 200kbp t intron poly A fragment used to generate riboprobe for in situ
nucleotides of SV40 sequence are therefore present in thehybridization.
mature transgene mRNA. Since the porcine TGF-b1 cDNA
is highly homologous to endogenous mouse TGF-b1 cDNA
and therefore not readily distinguished by Northern blot
analysis, the t intron-poly A fragment was used to makenovision, Springdale, AZ and was used at dilution of 1:200. Rabbit
riboprobes for in situ hybridization for the detection of theantiserum against human pro-SP-C (68514) was made in our labora-
transgenic mRNA.tory and was used at dilution of 1:1000. Rabbit antiserum against
rat CCSP was a gift from Dr. Gurmukh Singh (Bedetti et al., 1987) In situ hybridization demonstrated the presence of
and was used at dilution of 1:5000. transgenic mRNA in distal respiratory epithelial cells in all
Immunohistochemical staining for TGF-b1, collagen I, and colla- transgenic embryos except for one of the Day 18.5
gen III was performed as described by Heine et al. (1990). In brief, 5- transgenic embryos. Transgenic mRNA was detected in epi-
mm paraf®n sections were deparaf®nized, treated with 3% hydrogen thelial cells of terminal lung buds but not of bronchioles in
peroxidase and hyaluronidase (1 mg/ml) for 30 min for each, and
both Day 16 and Day 18.5 transgenic embryos (Fig. 2A). Thethen blocked with 10% normal serum at room temperature for
level of expression was generally higher in Day 18.5 (Fig.45 min. Sections were incubated overnight at 47C with primary
2A, panel A) than in Day 16 transgenic lungs (Fig. 2A, panelantibody and developed using the Vector Elite ABC method. Anti-
C). This distribution of the transgene mRNA was consistentgen localization was enhanced using nickel-DAB followed with an
with the expression pattern of other cDNAs expressed inincubation with Tris±cobalt, and counterstained with nuclear fast
red. The immunohistochemical staining for pro-SP-C and CCSP transgenic mice bearing SP-C promoter-driven constructs
was performed as described above without hyaluronidase treat- (Glasser et al., 1991; Wert et al., 1993).
ment. Immuno¯uorescence staining of PCNA was performed as Immunohistochemical staining demonstrated that pro±
described previously (Zsengeller et al., 1994). Brie¯y, 10-mm frozen TGF-b1 protein was present in epithelial cells of terminal
sections were post®xed with 4% paraformaldehyde, blocked with lung buds from both normal (Fig. 2B, panel A) and transgenic
5% normal serum at room temperature for 2 hr, and then incubated
(Fig. 2B, panel B) Day 16 embryos. Endogenous TGF-b1 pro-with primary antibody overnight at 47C. Sections were then incu-
tein was detected in bronchiolar epithelial cells but wasbated with FITC-conjugated secondary antibody for 30 min at room
not detectable in distal airway epithelial cells in normaltemperature. Immuno¯uorescence staining for a-smooth muscle
embryos on Day 18.5 pc (Fig. 2B, panel C). TGF-b1 stainingactin was performed as described above without being incubated
was maintained in terminal bud epithelial cells in thewith the secondary antibody. The lack of primary antibody was
used as a negative control for each immunostaining technique. transgenic embryos on Day 18.5 pc (Fig. 2B, panel D). The
presence of TGF-b1 in bronchiolar epithelial cells in the
lungs from transgenic embryos on Day 18.5 pc indicated
that the expression pattern of endogenous TGF-b1 was notRESULTS
affected by the exogenous TGF-b1 expression.
Generation of SP-C±pTGF-b1 Transgenic Embryos
Arrested Lung Morphogenesis in TransgenicFigure 1 represents the chimeric SP-C±TGF-b1±t intron-
Embryospoly A gene construct used to produce transgenic embryos.
The Cys223 and Cys225 codons, located in the proregion of In all Day 18.5 transgenic embryos expressing the TGF-
b1 transgene (n  10), lung development failed to progressthe pre±pro form of the porcine TGF-b1, were replaced with
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FIG. 2A. Expression of SP-C-TGF-b1-t intron-poly A transgene. In situ hybridization analysis of transgenic mRNA. Signal was detected
in epithelial cells of terminal lung buds in both Day 16 (C) and Day 18.5 (A) transgenic mice but not in the lungs of their nontransgenic
littermates (D, B). Bar  500 mm.
FIG. 2B. Expression of SP-C-TGF-b1-t intron-poly A transgene. Immunohistochemical detection of TGF-b1 protein. TGF-b1 protein was
detected (black spots) in epithelial cells of terminal lung buds (arrow) but not of bronchioles (arrowhead) in normal Day 16 embryos (A).
The protein expression was increased in transgenic Day 16 fetal lungs but the cellular localization remained the same (B). In normal Day
18.5 fetal lungs, the protein was detected in epithelial cells of bronchioles (arrow) but not of distal lung parachyme (C), while in transgenic
Day 18.5 fetal lungs, the protein was detected in epithelial cells of both bronchioles and terminal lung buds (arrows) (D). Bar, 75 mm. b,
bronchiole.
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FIG. 3. (A) Hematoxylin-eosin staining of fetal lungs. Lungs from SP-C-TGF-b1 mice on Day 18.5 pc (B) were typical of the pseudoglandular
stage with numerous terminal lung buds (arrow) surrounded by extensive mesenchyme similar to the lungs from normal mice on Day 16
pc (C). Lungs of nontransgenic littermates on Day 18.5 pc (A) were already in saccular stage. Lungs from transgenic mice on Day 16 pc
(D) contain fewer terminal buds (arrows) than those seen in lungs of their normal littermates (C). Bar, 100 mm (A, B); 50 mm (C, D). b,
bronchioles. (B) Morphometric analysis of left lungs from embryos on Day 16 pc. Lung sections of transgenic embryos and control
littermates from two litters on Day 16 pc were prepared. Acinar buds/mm2 contained in the lungs from transgenic embryos were reduced
by 48% (litter 1, open box) and 20% (litter 2, open box) compared to those of their normal littermates (shaded boxes).
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beyond the late pseudoglandular or early canalicular stages in normal fetal lung on Day 16 pc. Collagen III protein was
detected by immunostaining in extracellular regions (Figs.(Fig. 3A, panel B). Extensive mesenchyme, similar to that
seen in normal Day 16 embryonic lung (Fig. 3A, panel C), 5E±5H). In contrast to the aberrant expression of collagen
I, the expression pattern of collagen III was similar in nor-was typical of the lungs from transgenic embryos on Day
18.5 pc. Lungs from their normal littermates and from one mal and transgenic littermates on Days 16 (Figs. 5E and 5F)
and 18.5 pc (Figs. 5G and 5H).transgenic embryo lacking detectable transgenic mRNA
were already in the saccular stage of development (Fig. 3A,
panel A), typical of lungs from normal embryos on Day 18.5
Abnormal Distribution of a-Smooth Muscle Actinpc. Morphogenesis of lungs from transgenic embryos on Day
16 pc (Fig. 3A, panel D) was also delayed and contained Immunostaining for a-smooth muscle actin demon-
strated that in embryonic lungs from control mice on Dayfewer terminal buds than the lungs of their normal lit-
termates (Fig. 3A, panel C). Morphometric analysis was per- 16 pc, a-smooth muscle actin was detected around devel-
oping bronchioles, around the stalks and clefts of branchingformed on the lungs from transgenic and nontransgenic lit-
termates on Day 16 pc (Fig. 3B). The left lungs of transgenic tubules, and around blood vessels, but was not detected
around the leading edges of branching epithelial tubules andembryos from litter 1 and litter 2 contained 48% (P 
0.0001) and 20% (P  0.0041) fewer terminal acinar buds terminal acinar buds at this time (Fig. 6A). In lungs from
transgenic mice on Day 16 pc, a-smooth muscle actin wasthan those from their nontransgenic littermates. Body
weight, length, and lung size of transgenic embryos on both detected around some terminal buds and at some leading
edges of branching tubules (Fig. 6B). Staining for a-smoothDay 16 and Day 18.5 pc were similar to those of their non-
transgenic littermates. The immunostaining pattern for muscle actin was detected uniformly around all terminal
lung buds and at the leading edges of branching tubules onproliferating cell nuclear antigen (PCNA) was not altered
in lungs from SP-C±TGF-b1 embryos (data not shown). Day 18.5 pc (Fig. 6D). In normal littermates on Day 18.5 pc,
a-smooth muscle actin staining was only detected around
blood vessels and at low levels surrounding the bronchioles
TGF-b1 Inhibited Lung Epithelial Cell (Fig. 6C).
Differentiation in the Transgenic Embryos
Immunohistochemical staining for CCSP, a nonciliated
secretory cell marker and for pro±SP-C, a Type II cell spe- DISCUSSION
ci®c marker, was performed to determine the effect of TGF-
b1 on respiratory epithelial cell differentiation (Fig. 4). Lung morphogenesis of transgenic mouse embryos bear-
ing a chimeric SP-C±pTGF-b1 gene was assessed on DaysCCSP protein was ®rst detected on Fetal Day 17 in the
normal mouse lung (unpublished data). CCSP was readily 16 and 18.5 pc. The expression of the transgene was detected
in epithelial cells of terminal buds of the developing lungsdetected in bronchiolar epithelial cells in normal mice on
Day 18.5 pc (Fig. 4A) but was barely detectable in lungs by in situ hybridization and by immunocytochemical stain-
ing. While branching morphogenesis was slightly delayed,from transgenic mice on Day 18.5 pc (Fig. 4B). Pro±SP-C
protein, which is normally expressed in epithelial cells of the dilation of terminal buds, thinning of mesenchyme, as
well as lung epithelial cell differentiation, typical of theterminal lung buds on Day 16 pc (Fig. 4C) and at a higher
level in differentiated Type II epithelial cells on Day 18.5 canalicular and saccular periods of lung morphogenesis, was
inhibited by the expression of the TGF-b1. The presentpc (Fig. 4E), was barely detectable in terminal bud epithelial
cells from both Day 16 (Fig. 4D) and Day 18.5 pc (Fig. 4F) ®ndings support a role for TGF-b1 or related family mem-
bers in the regulation of lung morphogenesis and differentia-transgenic embryos, indicating that expression of both dif-
ferentiation-dependent markers was inhibited by expression tion.
Expression of TGF-b1 transgene in the lungs of SP-C±of the TGF-b1 transgene.
TGF-b1 transgenic mice arrested sacculation and also
slightly inhibited branching morphogenesis. The inhibition
Collagen I and Collagen III Deposition in Lungs of of branching morphogenesis is not as dramatic as that seen
Transgenic Embryos in mouse lung explants treated with TGF-b1. TGF-b1 treat-
ment of mouse lung explants in vitro blocked early stageIn nontransgenic littermates, collagen I protein was de-
tected by immunohistochemical staining in epithelial cells branching morphogenesis (Serra et al., 1994). This discrep-
ancy may be related to the differences between the twoof terminal lung buds on Day 16 (Fig. 5A) and primarily in
bronchiolar epithelial cells on Day 18.5 (Fig. 5C). The pat- experimental systems. Cultured mouse lung explants fail to
undergo sacculation in vitro. TGF-b1 treatment of embryostern of collagen I expression was not altered in lungs from
transgenic mice on Day 16 pc (Fig. 5B). On Day 18.5 pc, (Day 11) blocked early stages of branching morphogenesis
and these explants generally do not differentiate beyond thecollagen I was present at normal levels in bronchiolar epi-
thelial cells; however, the expression of collagen I was also pseudoglandular stage of development, limiting their utility
in assessing the effects of TGF-b1 on sacculation. Further-maintained in many epithelial cells of terminal lung buds
of transgenic embryos (Fig. 5D), similar to the pattern seen more, relatively high concentrations of TGF-b1 were re-
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FIG. 4. Immunohistochemical staining of CCSP and pro-SP-C. CCSP protein was detected (black spots) in bronchiolar epithelial cells
(arrow) of control embryos on Day 18.5 pc (A) but was barely detectable in the lungs of the transgenic littermates (B, arrowhead). Pro-SP-
C staining was detected in epithelial cells of terminal lung buds (arrow) in normal embryos on Day 16 pc (C) and at a higher levels in
differentiated Type II cells of control embryos on Day 18.5 pc (E, arrow) and was not detectable in bronchiolar epithelial cells (arrowhead)
in these lungs. In transgenic mice on both Day 16 (D) and Day 18.5 (F) pc, pro-SP-C was barely detectable in epithelial cells of terminal
lung buds. Bar, 100 mm (A±D); 75 mm (E, F). b, bronchiole.
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FIG. 6. Immuno¯uorescence staining of a-smooth muscle actin. In control mice on Day 16 pc (A), staining for a-smooth muscle actin
was readily detected around blood vessels, bronchioles, the stalks and clefts of branching tubules (arrows) and was barely detectable around
terminal lung buds and the leading edges of branching epithelial tubules (asterisks). Staining was detected around some terminal buds
(arrow) and some leading edges of branching tubules (asterisks) in transgenic mice on Day 16 pc (B) and was detected uniformly around
all the terminal buds (arrow) and leading edges of branching tubules (asterisks) in transgenic mice on Day 18.5 pc (D). In control mice on
Day 18.5 pc (C), staining for a-smooth muscle actin was intense around large blood vessels (asterisk) and was at low levels around
bronchioles (arrow). Bar, 64 mm. b, bronchiole; v, blood vessel.
quired to block branching morphogenesis in lung explant cally inhibit branching morphogenesis. The effects of TGF-
b1 on lung morphogenesis in SP-C±TGF-b1 transgenicculture that may not be achieved in the lungs of transgenic
mice. In the present studies, TGF-b1 transgene mRNA in- mice were similar to those seen in studies of mammary
gland morphogenesis (Jhappan et al., 1993). The mammarycreased from Day 16 to Day 18.5, as expected from the
normal pattern of murine SP-C and of transgenes expressed gland undergoes rapid ductal elongation and branching at
puberty, forming secretory alveolar structures during preg-with the SP-C promoter (Korfhagen et al., 1990; Glasser et
al., 1991; Wert et al., 1993). Since SP-C-dependent expres- nancy in preparation for lactation. Expression of TGF-b1 in
the mammary epithelium, directed by a whey±acidic pro-sion is relatively low early in gestation, the level of TGF-
b1 produced by the transgene may be inadequate to dramati- tein (WAP) gene promoter, inhibited pregnancy-induced lo-
FIG. 5. Immunohistochemical staining of collagen I and collagen III. Collagen I protein (A±D) was detected in epithelial cells of terminal
lung buds (arrow) in both normal (A) and transgenic (B) embryos on Day 16 pc. In control mice on Day 18.5 pc, collagen I protein was
detected primarily in bronchiolar epithelial cells (arrow) (C). Collagen I was detected in epithelial cells of both bronchioles and terminal
lung buds (arrows) in transgenic mice on Day 18.5 pc (D). Collagen III protein (E±H) was detected in the extracellular space surrounding
airway epithelial tubules (arrows) and blood vessels in both transgenic embryos (F, H) and their nontransgenic littermates (E, G) on Days
16 (E, F) and 18.5 (G, H) pc. Bar, 100 mm (A±D); 75 mm (E±H). b, bronchiole; v, blood vessel.
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buloalveolar development but did not alter puberty-induced While collagen III deposition was not affected, collagen I
expression persisted in epithelial cells of terminal acinarductal growth and branching morphogenesis.
Expression of active TGF-b1 in the lungs of SP-C±TGF- buds from transgenic mice on Day 18.5 pc. The abnormal
expression of collagen I in the transgenic mice may be re-b1 transgenic mice also markedly inhibited fetal lung epi-
thelial cell differentiation as assessed by immunostaining lated to a generalized arrest of lung morphogenesis. How-
ever, since TGF-b1 regulates collagen I gene expression infor CCSP and pro±SP-C. CCSP protein is ®rst detected in
conducting airway epithelial cells at 17 days pc, with its vitro, the persistent collagen I expression may be related to
the SP-C±TGF-b1 transgene expression in terminal acinarexpression increasing in association with the morphological
differentiation of conducting airway epithelial cells (unpub- buds. The abnormal expression of collagen I in distal air-
ways may inhibit the expansion of distal airways and con-lished data). Pro±SP-C protein expression increases mark-
edly in distal airway epithelium after the pseudoglandular tribute to the defective sacculation seen in the SP-C±TGF-
b1 mice.stage (unpublished data) and is associated with increased
Type II cell differentiation. Therefore, CCSP and pro±SP-C Expression of a-smooth muscle actin was also abnormal
in distal airways in transgenic embryos. Staining of a-were chosen for assessing proximal and distal lung epithe-
lial differentiation. The present ®ndings were consistent smooth muscle actin was abnormally detected in the area
surrounding the terminal lung buds and the leading edgeswith previous in vitro ®ndings that TGF-b1 inhibited SP-
A (Whitsett et al., 1987) and SP-C expression (Maniscalco et of branching tubules of SP-C±TGF-b1 transgenic mice, sug-
gesting that TGF-b1 may in¯uence smooth muscle cell/al., 1994) in embryonic lungs and inhibited the stimulatory
effects of EGF on SP-A (Whitsett et al., 1987) and phospho- myo®broblast differentiation. This is consistent with the
previous ®ndings that TGF-b1 stimulates the transforma-lipid (Torday and Kourembanas, 1990) synthesis, supporting
the hypothesis that TGF-b1 may play an important role in tion of ®broblasts into myo®broblasts and increases a-
smooth muscle actin expression of myo®broblasts (Gres-suppressing lung epithelial differentiation.
While TGF-b1 inhibited respiratory epithelial cell differ- sner, 1992; Desmouliere et al., 1993; Ronnov-Jessen and
Peterson, 1993). Normally, a-smooth muscle actin is ex-entiation, PCNA staining was not altered in the lungs of
SP-C±TGF-b1 transgenic mice, suggesting that the alter- pressed surrounding the clefts and the stalks but not the
leading edges of lung epithelial tubules during the pseudo-ations in lung morphogenesis were not directly related to
the observable changes in cell growth. Alterations in cell glandular stage. Staining for a-smooth muscle actin sur-
rounds bronchioles and vessels but is not present in distalproliferation caused profound changes in lung development
as seen in the lungs of embryos homozygous for N-myc airways of lungs during the saccular stage (Mitchell et al.,
1990; Roman et al., 1992; Fig. 6), being colocalized withdisruption (Charron et al., 1992; Sawai et al., 1993) or N-
myc mutation (Moens et al., 1992; 1993), which expressed that for extracellular TGF-b1 (Heine et al., 1990). These
®ndings support the hypothesis that TGF-b1 may regulatea lower than normal level of N-myc transcripts. These lungs
were smaller with fewer branches, which contributed to the expression ofa-smooth muscle actin and the differentia-
tion of pulmonary smooth muscle cells/myo®broblasts.prenatal and perinatal lethality. Inhibition of cell prolifera-
tion was observed in lung explants treated with TGF-b1 The abnormal distribution of a-smooth muscle actin may
be directly caused by the expression of the SP-C±TGF-b1(Serra et al., 1994) and in the skin of transgenic mice ex-
pressing the TGF-b1 transgene in the epidermis (Sellheyer transgene in distal airway epithelial cells. The normal ex-
pression pattern of a-smooth muscle actin suggests thatet al., 1993) as assessed by [3H]thymidine and 5-bromode-
oxyuridine labeling, respectively. In the present studies, smooth muscle cells/myo®broblasts may be involved in
lung morphogenesis, providing a mesenchymal in¯uencechanges in cell proliferation were not observed by PCNA
staining. However, subtle changes in cell proliferation that stabilizes the branching points and allows further
expansion of distal leading edges of epithelial tubules andwould not be easily assessed with PCNA staining.
Deposition of collagen III was unchanged, indicating that terminal buds. The abnormal distribution of smooth muscle
cells/myo®broblasts surrounding the leading edges of epi-the extensive mesenchyme maintained in the lungs of SP-
C±TGF-b1 transgenic mice was not related to ®brogenic thelial tubules and terminal buds may tether the distal air-
ways and inhibit the expansion of the terminal lung buds,effects of the TGF-b1 transgene. Collagen deposition in the
epidermis of newborn transgenic mice expressing active thereby contributing to the defective sacculation observed
in the lungs from SP-C±TGF-b1 transgenic mice. This ab-TGF-b1 was also unaltered (Sellheyer et al., 1993). How-
ever, ®brotic lesions were produced in the liver of adult normal distribution of smooth muscle cells/myo®broblasts
may provide a barrier between mesenchymal, endothelial,transgenic mice expressing active TGF-b1 under the control
of the albumin protein gene promoter (Sanderson et al., and distal epithelial cells that may inhibit cell±cell interac-
tions essential for epithelial cell differentiation during the1995), demonstrating that TGF-b1-induced ®brosis in vivo
may be tissue- and developmental stage-speci®c. The persis- canalicular and saccular stages of lung development.
The lack of sacculation in the lungs of SP-C±TGF-b1tence of lung mesenchyme in SP-C±TGF-b1 transgenic
mice may be related to a generalized arrest of lung morpho- transgenic mice also suggests that expression of TGF-b1
may inhibit fetal lung ¯uid secretion. Fluid secretion bygenesis that maintains extensive mesenchyme normally
present in the pseudoglandular lung. fetal lung epithelium plays an important role in lung mor-
Copyright q 1996 by Academic Press, Inc. All rights of reproduction in any form reserved.
/ 6x0c$$8189 03-29-96 00:17:30 dba Dev Bio
237TGF-b1 In¯uences Lung Morphogenesis
Lam, P., Thompson, L. L., Roberts, A. B., and Sporn, M. B. (1987).phogenesis. Accumulation of fetal lung ¯uid accelerated
Role of transforming growth factor-b in the development of thewhile a decrease of fetal lung ¯uid retarded lung growth
mouse embryo. J. Cell Biol. 105, 2861±2876.and sacculation in studies of tracheal ligation and chronic
Heine, U. I., Munoz, E. F., Flanders, K. C., Roberts, A. B., and Sporn,lung ¯uid drainage in fetal lambs (Alcorn et al., 1977). Air-
M. B. (1990). Colocalization of TGF-beta 1 and collagen I andway epithelial cells actively secrete ¯uid by a chloride de-
III, ®bronectin and glycosaminoglycans during lung branching
pendent mechanism (McCray et al., 1992a,b). We speculate morphogenesis. Development 109, 29±36.
that TGF-b1 may have in¯uenced ¯uid secretion, inhibiting Jhappan, C., Geiser, A. G., Kordon, E. C., Bagheri, D., Henningh-
fetal lung sacculation in the SP-C±TGF-b1 transgenic mice. ausen, L., Roberts, A. B., Smith, G. H., and Merlino, G. (1993).
In summary, the ®nding that TGF-b1 inhibits lung Targeting expression of a transforming growth factor b1
branching morphogenesis, epithelial cell differentiation, transgene to the pregnant mammary gland inhibits alveolar de-
velopment and lactation. EMBO J. 12, 1835±1845.and sacculation supports the concept that TGF-b1 plays an
Korfhagen, T. R., Glasser, S. W., Wert, S. E., Mruno, M. D., Daugh-inhibitory role during lung development.
erty, C. C., McNeish, J. D., Stock, J. L., Potter, S. S., and Whitsett,
J. A. (1990). Cis-acting sequences from a human surfactant pro-
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